Drug Shortage Report for VOLUVEN
Report ID | 38004 |
Drug Identification Number | 02278057 |
Brand name | VOLUVEN |
Common or Proper name | Voluven |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | HYDROXYETHYL STARCH 130/0.4 |
Strength(s) | 6% |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 250 mL Bag |
ATC code | B05AA |
ATC description | BLOOD AND RELATED PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-02-01 |
Actual start date | |
Estimated end date | 2018-03-01 |
Actual end date | 2018-03-05 |
Shortage status | Resolved |
Updated date | 2018-03-06 |
Company comments | During the supply shortage, Voluven 500 mL Bag and Volulyte 250 mL Bag will be available for substitution. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-03-06 | English | Compare |
v5 | 2018-03-02 | French | Compare |
v4 | 2018-03-02 | English | Compare |
v3 | 2018-02-02 | English | Compare |
v2 | 2018-02-01 | French | Compare |
v1 | 2018-02-01 | English | Compare |
Showing 1 to 6 of 6